Federico Mauri

Federico Mauri currently serves as a Principal Scientist at Boehringer Ingelheim since March 2021, having previously held the position of Associate Principal Scientist. Prior to this role, Federico Mauri worked as a Post-Doc at Université libre de Bruxelles from April 2013 to March 2021, focusing on cancer stem cells and skin tumor progression under the supervision of Prof. Cedric Blanpain. Earlier experience includes a PhD and Post-Doc at the Institute of Molecular Biotechnology in Vienna, Austria, where research centered on cell growth regulation and RNAi screens. Federico Mauri began the scientific career as an undergraduate student at Laboratorio Nazionale CIB, investigating post-translational modifications of the p53 tumor suppressor during a master's thesis. Educational qualifications include a Ph.D. in Molecular Biology from the University of Vienna and dual master's degrees in Medical Biotechnology from Università degli Studi di Trieste.